These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11855794)

  • 41. Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification.
    Mackness B; Mackness MI; Arrol S; Turkie W; Durrington PN
    FEBS Lett; 1998 Feb; 423(1):57-60. PubMed ID: 9506841
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HDL capacity to inhibit LDL oxidation in well-trained triathletes.
    Brites F; Zago V; Verona J; Muzzio ML; Wikinski R; Schreier L
    Life Sci; 2006 May; 78(26):3074-81. PubMed ID: 16488445
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activation of paraoxonase 1 is associated with HDL remodeling ex vivo.
    Gugliucci A
    Clin Chim Acta; 2014 Feb; 429():38-45. PubMed ID: 24280342
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Microencapsulated Pomegranate Modifies the Composition and Function of High-Density Lipoproteins (HDL) in New Zealand Rabbits.
    Dorantes-Morales A; Estrada-Luna D; Bautista-Pérez R; Betanzos-Cabrera G; Luna-Luna M; Flores-Castillo C; Vargas-Alarcón G; Fragoso JM; Pérez-Méndez Ó; Carreón-Torres E
    Molecules; 2020 Jul; 25(14):. PubMed ID: 32708063
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum paraoxonase activity is decreased in uremic patients.
    Schiavon R; De Fanti E; Giavarina D; Biasioli S; Cavalcanti G; Guidi G
    Clin Chim Acta; 1996 Mar; 247(1-2):71-80. PubMed ID: 8920228
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Apolipoprotein A-I promotes the formation of phosphatidylcholine core aldehydes that are hydrolyzed by paraoxonase (PON-1) during high density lipoprotein oxidation with a peroxynitrite donor.
    Ahmed Z; Ravandi A; Maguire GF; Emili A; Draganov D; La Du BN; Kuksis A; Connelly PW
    J Biol Chem; 2001 Jul; 276(27):24473-81. PubMed ID: 11320081
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vitamin C preserves the cardio-protective paraoxonase activity of high-density lipoprotein during oxidant stress.
    Calla MS; Lynch SM
    Arch Biochem Biophys; 2006 Aug; 452(2):129-37. PubMed ID: 16854368
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased susceptibility to peroxidation of VLDL from non-insulin-dependent diabetic patients: a possible correlation with fatty acid composition.
    Rabini RA; Tesei M; Galeazzi T; Dousset N; Ferretti G; Mazzanti L
    Mol Cell Biochem; 1999 Sep; 199(1-2):63-7. PubMed ID: 10544953
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes.
    Rosenblat M; Karry R; Aviram M
    Atherosclerosis; 2006 Jul; 187(1):74-81. PubMed ID: 16229851
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High-density lipoprotein composition and paraoxonase activity in Type I diabetes.
    Valabhji J; McColl AJ; Schachter M; Dhanjil S; Richmond W; Elkeles RS
    Clin Sci (Lond); 2001 Dec; 101(6):659-70. PubMed ID: 11724654
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PON1 paraoxonase activity is reduced during HDL oxidation and is an indicator of HDL antioxidant capacity.
    Jaouad L; Milochevitch C; Khalil A
    Free Radic Res; 2003 Jan; 37(1):77-83. PubMed ID: 12653220
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Significant association of lipid peroxidation products with high density lipoproteins.
    Hahn M; Subbiah MT
    Biochem Mol Biol Int; 1994 Jul; 33(4):699-704. PubMed ID: 7981657
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Determination of paraoxonase activities in serum and HDL].
    Fu Q; Liu B
    Hua Xi Yi Ke Da Xue Xue Bao; 2001 Sep; 32(3):459-61. PubMed ID: 12536594
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Atorvastatin effect on high-density lipoprotein-associated paraoxonase activity and oxidative DNA damage.
    Harangi M; Seres I; Varga Z; Emri G; Szilvássy Z; Paragh G; Remenyik E
    Eur J Clin Pharmacol; 2004 Dec; 60(10):685-91. PubMed ID: 15490140
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants.
    Aviram M; Rosenblat M; Billecke S; Erogul J; Sorenson R; Bisgaier CL; Newton RS; La Du B
    Free Radic Biol Med; 1999 Apr; 26(7-8):892-904. PubMed ID: 10232833
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Short-term feeding of atherogenic diet to mice results in reduction of HDL and paraoxonase that may be mediated by an immune mechanism.
    Hedrick CC; Hassan K; Hough GP; Yoo JH; Simzar S; Quinto CR; Kim SM; Dooley A; Langi S; Hama SY; Navab M; Witztum JL; Fogelman AM
    Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):1946-52. PubMed ID: 10938016
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Glycation of paraoxonase-1 inhibits its activity and impairs the ability of high-density lipoprotein to metabolize membrane lipid hydroperoxides.
    Mastorikou M; Mackness B; Liu Y; Mackness M
    Diabet Med; 2008 Sep; 25(9):1049-55. PubMed ID: 18937674
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of serum paraoxonase activity with insulin sensitivity and oxidative stress in hyperthyroid and TSH-suppressed nodular goitre patients.
    Yavuz DG; Yüksel M; Deyneli O; Ozen Y; Aydin H; Akalin S
    Clin Endocrinol (Oxf); 2004 Oct; 61(4):515-21. PubMed ID: 15473886
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reactivity of lecithin-cholesterol acyl transferase (LCAT) towards glycated high-density lipoproteins (HDL).
    Fournier N; Myara I; Atger V; Moatti N
    Clin Chim Acta; 1995 Jan; 234(1-2):47-61. PubMed ID: 7758222
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Protective effect of paraoxonase 1 of high-density lipoprotein in type 2 diabetic patients with nephropathy.
    Li C; Gu Q
    Nephrology (Carlton); 2009 Aug; 14(5):514-20. PubMed ID: 19207863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.